New Risk • Apr 21
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CN¥31m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥31m free cash flow). Earnings have declined by 57% per year over the past 5 years. Reported Earnings • Apr 21
Full year 2025 earnings released: CN¥0.15 loss per share (vs CN¥0.46 loss in FY 2024) Full year 2025 results: CN¥0.15 loss per share (improved from CN¥0.46 loss in FY 2024). Revenue: CN¥329.7m (down 11% from FY 2024). Net loss: CN¥53.1m (loss narrowed 68% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Annonce • Apr 21
Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 15, 2026 Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 15, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Quanzhou, Fujian China Annonce • Mar 30
Yongyue Science&Technology Co.,Ltd to Report Q1, 2026 Results on Apr 30, 2026 Yongyue Science&Technology Co.,Ltd announced that they will report Q1, 2026 results on Apr 30, 2026 Annonce • Dec 26
Yongyue Science&Technology Co.,Ltd to Report Fiscal Year 2025 Results on Apr 21, 2026 Yongyue Science&Technology Co.,Ltd announced that they will report fiscal year 2025 results on Apr 21, 2026 New Risk • Dec 12
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 65% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.5% average weekly change). Board Change • Oct 29
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Shuzhi Xie was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Annonce • Sep 30
Yongyue Science&Technology Co.,Ltd to Report Q3, 2025 Results on Oct 31, 2025 Yongyue Science&Technology Co.,Ltd announced that they will report Q3, 2025 results on Oct 31, 2025 New Risk • Jul 08
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 9.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥38m free cash flow). Share price has been highly volatile over the past 3 months (9.4% average weekly change). Earnings have declined by 72% per year over the past 5 years. Annonce • Jun 30
Yongyue Science&Technology Co.,Ltd to Report First Half, 2025 Results on Aug 30, 2025 Yongyue Science&Technology Co.,Ltd announced that they will report first half, 2025 results on Aug 30, 2025 New Risk • Jun 06
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥38m free cash flow). Earnings have declined by 72% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.3% average weekly change). New Risk • May 08
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CN¥38m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CN¥38m free cash flow). Earnings have declined by 72% per year over the past 5 years. Reported Earnings • Apr 03
Full year 2024 earnings released: CN¥0.46 loss per share (vs CN¥0.19 loss in FY 2023) Full year 2024 results: CN¥0.46 loss per share (further deteriorated from CN¥0.19 loss in FY 2023). Revenue: CN¥370.4m (up 9.7% from FY 2023). Net loss: CN¥165.5m (loss widened 136% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance. Annonce • Apr 03
Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 09, 2025 Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 09, 2025, at 14:00 China Standard Time. Location: Office Building 5, College Student Entrepreneurship Park, East of Yongsheng Road and South of Ruifeng Road, Dazhong Subdistrict, Dafeng District, Yancheng, Jiangsu China Annonce • Mar 28
Yongyue Science&Technology Co.,Ltd to Report Q1, 2025 Results on Apr 30, 2025 Yongyue Science&Technology Co.,Ltd announced that they will report Q1, 2025 results on Apr 30, 2025 Annonce • Dec 27
Yongyue Science&Technology Co.,Ltd to Report Fiscal Year 2024 Results on Mar 31, 2025 Yongyue Science&Technology Co.,Ltd announced that they will report fiscal year 2024 results on Mar 31, 2025 Reported Earnings • Nov 02
Third quarter 2024 earnings released: CN¥0.025 loss per share (vs CN¥0.037 loss in 3Q 2023) Third quarter 2024 results: CN¥0.025 loss per share (improved from CN¥0.037 loss in 3Q 2023). Revenue: CN¥103.9m (up 16% from 3Q 2023). Net loss: CN¥8.91m (loss narrowed 32% from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance. Annonce • Sep 30
Yongyue Science&Technology Co.,Ltd to Report Q3, 2024 Results on Oct 30, 2024 Yongyue Science&Technology Co.,Ltd announced that they will report Q3, 2024 results on Oct 30, 2024 Reported Earnings • Aug 29
Second quarter 2024 earnings released: CN¥0.036 loss per share (vs CN¥0.032 loss in 2Q 2023) Second quarter 2024 results: CN¥0.036 loss per share (further deteriorated from CN¥0.032 loss in 2Q 2023). Revenue: CN¥94.0m (up 7.4% from 2Q 2023). Net loss: CN¥12.8m (loss widened 11% from 2Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 68 percentage points per year, which is a significant difference in performance. Annonce • Jun 28
Yongyue Science&Technology Co.,Ltd to Report First Half, 2024 Results on Aug 29, 2024 Yongyue Science&Technology Co.,Ltd announced that they will report first half, 2024 results on Aug 29, 2024 New Risk • Jun 25
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: CN¥707.0m (US$97.3m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 77% per year over the past 5 years. Minor Risk Market cap is less than US$100m (CN¥707.0m market cap, or US$97.3m). New Risk • Jun 05
New major risk - Revenue and earnings growth Earnings have declined by 77% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (16% average weekly change). Earnings have declined by 77% per year over the past 5 years. New Risk • May 14
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 74% per year over the past 5 years. Minor Risk Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Annonce • May 01
Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 30, 2024 Yongyue Science&Technology Co.,Ltd, Annual General Meeting, May 30, 2024, at 14:00 China Standard Time. Location: 7F, No. 16, Hongwu North Road, Xuanwu District, Nanjing, Jiangsu China Annonce • Mar 29
Yongyue Science&Technology Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024 Yongyue Science&Technology Co.,Ltd announced that they will report Q1, 2024 results on Apr 30, 2024 New Risk • Feb 27
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 74% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (9.0% average weekly change). Annonce • Feb 27
Yongyue Science&Technology Co.,Ltd (SHSE:603879) announces an Equity Buyback for CNY 30 million worth of its shares. Yongyue Science&Technology Co.,Ltd (SHSE:603879) announces a share repurchase program. Under the program, the company will repurchase up to CNY 30 million worth of its shares. The shares will be repurchased at a price not more than CNY 6 per share. The repurchased shares will be used to safeguard the company's value and shareholders' rights. The program will be valid for a period of 3 months. Annonce • Dec 29
Yongyue Science&Technology Co.,Ltd to Report Fiscal Year 2023 Results on Apr 30, 2024 Yongyue Science&Technology Co.,Ltd announced that they will report fiscal year 2023 results on Apr 30, 2024 Reported Earnings • Aug 30
Second quarter 2023 earnings released: CN¥0.032 loss per share (vs CN¥0.008 loss in 2Q 2022) Second quarter 2023 results: CN¥0.032 loss per share (further deteriorated from CN¥0.008 loss in 2Q 2022). Revenue: CN¥87.5m (up 10% from 2Q 2022). Net loss: CN¥11.5m (loss widened 291% from 2Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 136 percentage points per year, which is a significant difference in performance. New Risk • Jul 25
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 65% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (6.7% average weekly change). Annonce • Jun 28
Yongyue Science&Technology Co.,Ltd to Report First Half, 2023 Results on Aug 30, 2023 Yongyue Science&Technology Co.,Ltd announced that they will report first half, 2023 results on Aug 30, 2023 Reported Earnings • Apr 29
First quarter 2023 earnings released: CN¥0.017 loss per share (vs CN¥0.006 loss in 1Q 2022) First quarter 2023 results: CN¥0.017 loss per share (further deteriorated from CN¥0.006 loss in 1Q 2022). Revenue: CN¥60.0m (up 13% from 1Q 2022). Net loss: CN¥6.00m (loss widened 185% from 1Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 102 percentage points per year, which is a significant difference in performance. Board Change • Nov 16
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. 2 independent directors (4 non-independent directors). GM & Vice Chairman Weida Xu is the most experienced director on the board, commencing their role in 2017. Independent Director Yu Wu was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Reported Earnings • Oct 28
Third quarter 2022 earnings released: CN¥0.032 loss per share (vs CN¥0.003 profit in 3Q 2021) Third quarter 2022 results: CN¥0.032 loss per share (down from CN¥0.003 profit in 3Q 2021). Revenue: CN¥84.5m (down 18% from 3Q 2021). Net loss: CN¥11.5m (down CN¥12.6m from profit in 3Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance. Reported Earnings • Aug 31
Second quarter 2022 earnings released: CN¥0.008 loss per share (vs CN¥0.012 profit in 2Q 2021) Second quarter 2022 results: CN¥0.008 loss per share (down from CN¥0.012 profit in 2Q 2021). Revenue: CN¥79.4m (down 32% from 2Q 2021). Net loss: CN¥2.95m (down 181% from profit in 2Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance. Board Change • Aug 25
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 5 new directors. 1 experienced director. No highly experienced directors. 2 independent directors (4 non-independent directors). GM & Vice Chairman Weida Xu is the most experienced director on the board, commencing their role in 2017. Independent Director Yu Wu was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Reported Earnings • May 02
First quarter 2022 earnings released: CN¥0.006 loss per share (vs CN¥0.008 profit in 1Q 2021) First quarter 2022 results: CN¥0.006 loss per share (down from CN¥0.008 profit in 1Q 2021). Revenue: CN¥53.2m (down 43% from 1Q 2021). Net loss: CN¥2.11m (down 166% from profit in 1Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 12 experienced directors. No highly experienced directors. 3 independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Apr 21
Full year 2021 earnings released: EPS: CN¥0.018 (vs CN¥0.015 in FY 2020) Full year 2021 results: EPS: CN¥0.018 (up from CN¥0.015 in FY 2020). Revenue: CN¥396.2m (down 2.5% from FY 2020). Net income: CN¥6.43m (up 2.8% from FY 2020). Profit margin: 1.6% (up from 1.5% in FY 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings. Reported Earnings • Oct 28
Third quarter 2021 earnings released: EPS CN¥0.003 (vs CN¥0.008 loss in 3Q 2020) The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: CN¥103.4m (down 10.0% from 3Q 2020). Net income: CN¥1.13m (up CN¥3.91m from 3Q 2020). Profit margin: 1.1% (up from net loss in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 56% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings. Reported Earnings • Aug 20
Second quarter 2021 earnings released: EPS CN¥0.012 (vs CN¥0.014 in 2Q 2020) The company reported a mediocre second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥116.1m (up 33% from 2Q 2020). Net income: CN¥3.64m (down 27% from 2Q 2020). Profit margin: 3.1% (down from 5.7% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings. Reported Earnings • Apr 20
Full year 2020 earnings released: EPS CN¥0.02 (vs CN¥0.086 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥406.4m (down 5.2% from FY 2019). Net income: CN¥6.25m (down 74% from FY 2019). Profit margin: 1.5% (down from 5.7% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Feb 08
New 90-day low: CN¥6.36 The company is down 25% from its price of CN¥8.49 on 10 November 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period. Annonce • Jan 22
Jiangsu Huaying Enterprise Management Co., Ltd. completed the acquisition of 17.1% stake in Yongyue Science&Technology Co.,Ltd (SHSE:603879) from Fu Wenchang, Fu Shuifa, Fu Wenying and Chen Zhishan. Jiangsu Huaying Enterprise Management Co., Ltd. signed a share transfer intention agreement to acquire 17.1% stake in Yongyue Science&Technology Co.,Ltd (SHSE:603879) from Fu Wenchang, Fu Shuifa, Fu Wenying and Chen Zhishan for approximately CNY 620 million on November 11, 2020. Under the terms of the transaction, Jiangsu Huaying will acquire 47.8 million shares of Yongyue Science&Technology for CNY 12.8 per share. Within 3 working days from the date of signing the agreement, a deposit of CNY 100 million shall be paid. Before the transaction, Fu Wenchang, Fu Shuifa, Fu Xiuzhen and Fu Wenying held 102.9 million shares or 36.83% stake while Chen Zhishan held 37.6 million shares or 13.46% stake in in Yongyue Science&Technology. Upon completion of the transaction, Fu Wenchang, Fu Shuifa, Fu Xiuzhen and Fu Wenying will hold 64.5 million shares or 23.08% stake while Chen Zhishan will hold 28.2 million shares or 10.1% stake.
Jiangsu Huaying Enterprise Management Co., Ltd. completed the acquisition of 17.1% stake in Yongyue Science&Technology Co.,Ltd (SHSE:603879) from Fu Wenchang, Fu Shuifa, Fu Wenying and Chen Zhishan on January 20, 2021. Is New 90 Day High Low • Jan 06
New 90-day low: CN¥7.18 The company is down 2.0% from its price of CN¥7.36 on 30 September 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period. Is New 90 Day High Low • Dec 01
New 90-day high: CN¥8.51 The company is up 3.0% from its price of CN¥8.30 on 02 September 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company outperformed over that time. However, its price trend is similar to the Chemicals industry, which is also up 3.0% over the same period. Reported Earnings • Oct 25
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥2.82m, down 88% from the prior year. Total revenue was CN¥370.5m over the last 12 months, down 22% from the prior year. Annonce • Oct 20
Yongyue Science&Technology Co.,Ltd to Report Q3, 2020 Results on Oct 24, 2020 Yongyue Science&Technology Co.,Ltd announced that they will report Q3, 2020 results on Oct 24, 2020 Annonce • Jul 09
Yongyue Science&Technology Co.,Ltd to Report First Half, 2020 Results on Aug 21, 2020 Yongyue Science&Technology Co.,Ltd announced that they will report first half, 2020 results on Aug 21, 2020